April 2026
1. LEND K, Twisk JWR, Koopman FA, Rudin A, et al
   Flare risk after oral glucocorticoid bridging with methotrexate or intra-articular bridging with triple therapy in early rheumatoid arthritis.
   J Intern Med. 2026 Apr 6. doi: 10.1111/joim.70094.
   

   >> Share

   
   October 2025
2. SHI J, Yu C, Ke D, Yuan X, et al
   Systemic neutrophil activation and N-formyl methionine-formyl peptide receptor-1 signaling define inflammatory endotypes in rheumatoid arthritis-associated lung involvement.
   J Intern Med. 2025 Oct 14. doi: 10.1111/joim.70030.
   

   >> Share

   
   May 2025
3. WADSTROM H, Askling J, Gedeborg R, Feltelius N, et al
   Non-steroidal anti-inflammatory drugs and risk of kidney cancer: A Swedish nationwide cohort study in the general and high-use populations.
   J Intern Med. 2025;297:505-517.
   

   >> Share

   
   April 2025
4. SYSOJEV AO, Delcoigne B, Frisell T, Alfredsson L, et al
   Common genetic variants do not impact clinical prediction of methotrexate treatment outcomes in early rheumatoid arthritis.
   J Intern Med. 2025 Apr 6. doi: 10.1111/joim.20087.
   

   >> Share

   
   January 2025
5. CHO Y, Yoon D, Khosrow-Khavar F, Song M, et al
   Cardiovascular, cancer, and infection risks of Janus kinase inhibitors in rheumatoid arthritis and ulcerative colitis: A nationwide cohort study.
   J Intern Med. 2025 Jan 27. doi: 10.1111/joim.20064.
   

   >> Share

   
   December 2023
6. RATERMAN HG
   Hypothyroidism and rheumatoid arthritis: Missing a link?
   J Intern Med. 2023 Dec 20. doi: 10.1111/joim.13762.
   

   >> Share

   
   November 2023
7. WALDENLIND K, Delcoigne B, Saevarsdottir S, Askling J, et al
   Disease-modifying antirheumatic drugs and risk of thyroxine-treated autoimmune thyroid disease in patients with rheumatoid arthritis.
   J Intern Med. 2023 Nov 22. doi: 10.1111/joim.13743.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share